Current Status of COVID-19 Vaccines Rollout Nationwide: July 2022 Update for the Attorney General Community
On July 13, the U.S. reached over 222.6 million persons (67.1% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Nearly 400,000 children under five years of age have…
Current Status of COVID-19 Vaccines Rollout Nationwide: June 2022 Update for the Attorney General Community
On June 17, the U.S. reached nearly 221.9 million persons (66.8% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 104.7 million persons in the U.S. have received…
Current Status of COVID-19 Vaccines Rollout Nationwide: May 2022 Update for the Attorney General Community
On May 16, the U.S. reached nearly 220.6 million persons (66.4% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 102 million persons in the U.S. have received…
Current Status of COVID-19 Vaccines Rollout Nationwide: March 2022 Update for the Attorney General Community
On March 24, the U.S. reached 255.1 million persons (76.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 217.3 million persons (65.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: February 2022 Update for the Attorney General Community
On February 18, the U.S. reached 252.5 million persons (76.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 214.5 million persons (64.6% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: January 2022 Update for the Attorney General Community
On January 18, the U.S. reached 249.4 million persons (75.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 209.3 million persons (63.0% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: December 2021 Update for the Attorney General Community
On December 20, the U.S. reached 241.6 million persons (72.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 203.9 million persons (61.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: November 2021 Update for the Attorney General Community
On November 30, the U.S. reached 232.8 million persons (70.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 196.8 million persons (59.3% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: October 2021 Update for the Attorney General Community
On October 22, the U.S. reached over 611.0 million total COVID-19 vaccine doses administered with 219.6 million persons (66.2% of the total U.S. population) having received at least one dose and 189.9 million persons (57.2% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine…
COVID-19 and Its Impacts on Substance Use and Overdose
Provisional Centers for Disease Control & Prevention (CDC) data show that U.S. drug overdose deaths increased by 30% in 2020 from the prior year, reaching an all-time high. Increases in overdose deaths were reported for synthetic opioids (primarily fentanyl), natural or semi-synthetic opioids (e.g., prescription pain medications), psychostimulants (e.g., methamphetamine), and cocaine. In many ways,…
